Non-Invasive Sexually Transmitted Disease Testing in Women Seeking Emergency Contraception or Urine Pregnancy Testing

Chlamydia Trachomatis Clinical Trial

Official title:

Non-Invasive Sexually Transmitted Disease Testing in Women Seeking Emergency Contraception or Urine Pregnancy Testing: Meeting the Needs of an At-Risk Population

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT00978848
• Other study ID #: PRO8120077
• Status: Completed
• Phase: N/A
• First received: September 16, 2009
• Last updated: May 17, 2016
• Start date: November 2009
• Est. completion date: April 2010

Study information

• Verified date: May 2016
• Source: University of Pittsburgh
• Contact: n/a
• Is FDA regulated: No
• Health authority: United States: Institutional Review Board
• Study type: Observational

Clinical Trial Summary

The purpose of this study is to determine the prevalence and treatment rates of T. vaginalis, C. trachomatis, and N. gonorrhoeae in women seeking emergency contraception or urine pregnancy testing in the Magee-Womens Hospital outpatient clinic using a non-invasive urine STD test.

Description:

This study has three primary objectives: 1) to determine the prevalence of T. vaginalis, C. trachomatis, and N. gonorrhoeae in women seeking emergency contraception or urine pregnancy testing - a population likely at increased risk of acquiring STDs; 2) to determine the rate of successful treatment in women diagnosed with STDs in this venue.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 305
• Est. completion date: April 2010
• Est. primary completion date: April 2010
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: Female
• Age group: 15 Years and older

Eligibility

Inclusion Criteria:

• Females at least age 15 at time of enrollment who are presenting at Magee-Womens Hospital for emergency contraception or urine pregnancy testing.

• Ability to provide written informed consent.

Exclusion Criteria:

• Diagnosis and/or treatment for an STD within 4 weeks of enrollment in the study.

Study Design

Observational Model: Case-Only, Time Perspective: Cross-Sectional

Related Conditions & MeSH terms

• Chlamydia Trachomatis
• Emergencies
• Gonorrhea
• Neisseria Gonorrhoeae Infection
• Sexually Transmitted Diseases
• Trichomonas Infections
• Trichomonas Vaginitis

Locations

Country	Name	City	State
United States	Magee-Womens Hospital of UPMC	Pittsburgh	Pennsylvania

Sponsors (2)

Lead Sponsor	Collaborator
University of Pittsburgh	Gen-Probe, Incorporated

Country where clinical trial is conducted

United States,